Modern active surveillance in low- and intermediate-risk prostate cancer without re-biopsy.

Lakes J; Al-Monajjed R; Busshoff I; Hübner A; Boschheidgen M; Valentin B; Antoch G; Albers P; Schimmöller L; Radtke JP

doi:10.1038/s41391-025-01010-6

← 뒤로

Modern active surveillance in low- and intermediate-risk prostate cancer without re-biopsy.

Prostate cancer and prostatic diseases 2025

Lakes J, Al-Monajjed R, Busshoff I, Hübner A, Boschheidgen M, Valentin B, Antoch G, Albers P, Schimmöller L, Radtke JP

원문 ↗ DOI ↗ BibTeX ↓ RIS ↓

이 논문을 인용하기

BibTeX ↓ RIS ↓

APA Lakes J, Al-Monajjed R, et al. (2025). Modern active surveillance in low- and intermediate-risk prostate cancer without re-biopsy.. Prostate cancer and prostatic diseases. https://doi.org/10.1038/s41391-025-01010-6

MLA Lakes J, et al.. "Modern active surveillance in low- and intermediate-risk prostate cancer without re-biopsy.." Prostate cancer and prostatic diseases, 2025.

PMID 40946100

DOI 10.1038/s41391-025-01010-6

같은 제1저자의 인용 많은 논문 (1)

Genetic Testing and Imaging in Men with Familial History or Genetic Predisposition of Prostate Cancer-Introducing the Prospective "ProFam-Risk" Study.
European urology open science 2026